Lepirudin anticoagulation for heparin-induced thrombocytopenia after cardiac surgery in a pediatric patient

Pharmacotherapy

Volumn 26, Issue 5 I, 2006, Pages 709-712

  Knoderer, Chad A ^a,b   Knoderer, Holly M ^a   Turrentine, Mark W ^a   Kumar, Manjusha ^a  

^a INDIANA UNIVERSITY   (United States)

^b RILEY HOSPITAL FOR CHILDREN   (United States)

Author keywords

Anticoagulation; Heparin induced thrombocytopenia; HIT; Lepirudin; Pediatric

Indexed keywords

ANTICOAGULANT AGENT; HEPARIN; LEPIRUDIN; WARFARIN;

ANTICOAGULATION; ARTICLE; CASE REPORT; CHILD; DOSE RESPONSE; DRUG EFFICACY; DRUG SAFETY; DRUG WITHDRAWAL; EXTRACORPOREAL OXYGENATION; HEART SURGERY; HEPARIN INDUCED THROMBOCYTOPENIA; HUMAN; MALE; PARTIAL THROMBOPLASTIN TIME; POSTOPERATIVE PERIOD; PRACTICE GUIDELINE; THROMBOCYTE COUNT; TREATMENT OUTCOME;

EID: 33646383074     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: 10.1592/phco.26.5.709     Document Type: Article

References (21)

1. Warkentin TE, Greinacher A. Heparin-induced thrombocytopenia: recognition, treatment, and prevention: the seventh ACCP conference on antithrombotic and thrombolytic therapy. Chest 2004;126(3 suppl):311S-37.
2. Warkentin TE, Levine MN, Hirsh J, et al. Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin. N Engl J Med 1995;332:1330-5.
3. Klenner AF, Lubenow N, Raschke R, Greinacher A. Heparin-induced thrombocytopenia in children: 12 new cases and review of the literature. Thromb Haemost 2004;91:719-24.
4. Schmugge M, Risch L, Huber AR, Benn A, Fischer JE. Heparin-induced thrombocytopenia-associated thrombosis in pediatric intensive care patients [online exclusive article]. Pediatrics 2002;109:e10. Available from http://pediatrics. aappublications.org/cgi/content/full/109/1/e10.
5. Warkentin TE, Sheppard JI, Horsewood P, et al. Impact of the patient population on the risk for heparin-induced thrombocytopenia. Blood 2000;96:1703-8.
6. Pouplard C, May MA, Iochmann S, et al. Antibodies to platelet factor 4-heparin after cardiopulmonary bypass in patients anticoagulated with unfractionated heparin or a low-molecular-weight heparin. Circulation 1999;99:2530-6.
7. Trossaert M, Gaillard A, Commin PL, et al. High incidence of anti-heparin/platelet factor 4 antibodies after cardiopulmonary bypass surgery. Br J Haematol 1998;101:653-5.
8. Warkentin TE, Greinacher A. Heparin-induced thrombocytopenia and cardiac surgery. Ann Thorac Surg 2003;76:2121-31.
9. Böning A, Morschheuser T, Bläse U, et al. Incidence of heparin-induced thrombocytopenia and therapeutic strategies in pediatric cardiac surgery. Ann Thorac Surg 2005;79:62-5.
10. Wilson DB. Acquired platelet defects. In: Nathan DG, Ginsburg D, Orkin SH, et al, eds. Nathan and Oski's hematology of infancy and children. Philadelphia, PA: Saunders, 2003:1613-14.
11. Dlott JS. Heparin-induced thrombocytopenia. In: Goodnight SH, Hathaway WE, eds. Disorders of hemostasis and thrombosis: a clinical guide. New York: McGraw-Hill, 2001:425-31.
12. Warkentin TE. Heparin-induced thrombocytopenia: pathogenesis and management. Br J Haematol 2003;121:535-55.
13. Jy W, Mao WW, Horstman LL, et al. A flow cytometric assay of platelet activation marker P-selectin (CD62P) distinguishes heparin-induced thrombocytopenia (HIT) from HIT with thrombosis (HITT). Thromb Haemost 1999;82:1255-9.
14. Mejak B, Giacomuzzi C, Heller E, et al. Argatroban usage for anticoagulation for ECMO on a post-cardiac patient with heparin-induced thrombocytopenia. J Extracorpor Technol 2004;36:178-81.
15. Dyke PC, Russo P, Mureebe L, et al. Argatroban for anticoagulation during cardiopulmonary bypass in an infant. Paediatr Anaesth 2005;15:328-33.
16. Nutescu EA, Wittkowsky AK. Direct thrombin inhibitors for anticoagulation. Ann Pharmacother 2004;38:99-109.
17. Nguyen TN, Gal P, Ransom JL, et al. Lepirudin use in a neonate with heparin-induced thrombocytopenia. Ann Pharmacother 2003;37:229-33.
18. Deitcher SR, Topoulos AP, Bartholomew JR, et al. Lepirudin anticoagulation for heparin-induced thrombocytopenia. J Pediatr 2002;140:264-6.
19. Dager WE, White RH. Low-molecular-weight heparin-induced thrombocytopenia in a child. Ann Pharmacother 2004;38:247-50.
20. Dager WE, Gosselin RC, Yoshikawa R, et al. Lepirudin in heparin-induced thrombocytopenia and extracorporeal membranous oxygenation. Ann Pharmacother 2004;38:598-601.
21. Warkentin TE, Kelton JG. A 14-year study of heparin-induced thrombocytopenia. Am J Med 1996;101:502-7.